A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets

Figure 2

The overall number of somatic mutations and neoantigens in Fujian and TCGA cohorts. (a) The frequency of mutated genes and their neoantigens in Fujian and TCGA and all GC samples in this study (n = 942). The fitted curve between the number of nonsilent somatic mutations and neoantigens in Fujian cohort (b), R² = 0.92, and TCGA cohort (c), R² = 0.88, respectively.

(a)

(b)

(c)